Literature DB >> 12592948

Health Value Added (HVA): linking strategy, performance, and measurement in healthcare organizations.

Nurit L Friedman1, Ehud Kokia, Joshua Shemer.   

Abstract

This paper describes "Health Value Added"--an innovative model that links performance measurement to strategy in health maintenance organizations. The HVA model was developed by Maccabi Healthcare Services, Israel's second largest HMO, with the aim of focusing all its activities on providing high quality care within budgetary and regulatory constraints. HVA draws upon theory and practice from strategic management and performance measurement in order to assess an HMO's ability to improve the health of its members. The model consists of four interrelated levels--mission, goals, systems, and resources--and builds on the existence of advanced computerized information systems that make comprehensive measurements available to decision makers in real time. HVA enables management to evaluate overall organizational performance as well as the performance of semi-autonomous units. In simple terms, the sophisticated use of performance measures can help healthcare organizations obtain more health for the same money.

Mesh:

Year:  2003        PMID: 12592948

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  3 in total

1.  Trends in statin therapy initiation during the period 2000-2010 in Israel.

Authors:  Varda Shalev; Clara Weil; Raanan Raz; Inbal Goldshtein; Dahlia Weitzman; Gabriel Chodick
Journal:  Eur J Clin Pharmacol       Date:  2014-01-25       Impact factor: 2.953

2.  Adherence to quality of care measurements among 58,182 patients with new onset diabetes and its association with mortality.

Authors:  Beatriz Hemo; Danit R Shahar; Dikla Geva; Anthony D Heymann
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 3.  Personalized Health Systems-Past, Present, and Future of Research Development and Implementation in Real-Life Environment.

Authors:  Hadas Lewy; Refael Barkan; Tomer Sela
Journal:  Front Med (Lausanne)       Date:  2019-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.